STERIMED

STERIMED has been active since 2003 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €759,376 and a net result of €309,279. Equity is growing by about 32% per year across the filed financial years. Its solvency ranks better than 46% of 9,689 sector peers (NACE 46, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).